The use of serum hCG as a marker of tumor progression and of the response of metastatic urothelial cancer to systemic chemotherapy.

Malkhasyan, Karen; Deshpande, Hari A; Adeniran, Adebowale J; Colberg, John W; Petrylak, Daniel P

Malkhasyan, Karen; Deshpande, Hari A; Adeniran, Adebowale J; Colberg, John W; Petrylak, Daniel P.

Afiliación

Malkhasyan K; Yale-New Haven Hospital, New Haven, Connecticut, USA.
Deshpande HA; Division of Oncology, Department of Medicine, Yale Comprehensive Cancer Center, Yale School of Medicine, New Haven, Connecticut, USA.
Adeniran AJ; Department of Pathology, Yale School of Medicine, New Haven, Connecticut, USA.
Colberg JW; Department of Urology, Yale School of Medicine, New Haven, Connecticut, USA.
Petrylak DP; Division of Oncology, Department of Medicine, Yale Comprehensive Cancer Center, Yale School of Medicine, New Haven, Connecticut, USA.

Oncology (Williston Park) ; 27(10): 1028, 1030, 2013 Oct.

Article en En | MEDLINE | ID: mdl-24367863

Asunto(s)

Biomarcadores de Tumor/sangre; Gonadotropina Coriónica Humana de Subunidad beta/sangre; Neoplasias de la Vejiga Urinaria/tratamiento farmacológico; Progresión de la Enfermedad; Femenino; Humanos; Persona de Mediana Edad; Metástasis de la Neoplasia; Neoplasias de la Vejiga Urinaria/sangre; Neoplasias de la Vejiga Urinaria/patología

Buscar en Google

Imprimir

XML

PubMed Links

Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Biomarcadores de Tumor / Gonadotropina Coriónica Humana de Subunidad beta Tipo de estudio: Observational_studies Límite: Female / Humans / Middle aged Idioma: En Revista: Oncology (Williston Park) Asunto de la revista: NEOPLASIAS Año: 2013 Tipo del documento: Article País de afiliación: Estados Unidos

Buscar en Google

Imprimir

XML

PubMed Links